Detail of the clinical trial
| Title of the trial | A Phase IIB, Randomized, Double-Blinded, Placebo-Controlled Study of Low Dose Cytarabine and Lintuzumab Compared to Low Dose Cytarabine and Placebo in Patients 60 Years of Age and Older with Previously Untreated AML. |
|---|---|
| EudraCT number | 2007-004761-17 |
| Protocol number | SG033-0003 |
| Sponsor | Seattle Genetics, Inc., Bothell, USA |
| Indications | Hemato-oncology |
| Diagnosis | acute myeloid leukaemia |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2008 |
| Date of approval by Institute (SÚKL) | 31.12.2008 |
| Date of approval by EC | 15.11.2008 |
| Date of initiation CT in ČR | |
| Date of ending CT in ČR | 13.2.2009 |
| Notice | The study has not been started from administrative reasons. |
| Sites |
2. Interní klinika, odd. klinické hematologie, FN Hradec Králové Oddělení klinické hematologie, FNKV Praha 10 1. interní klinika, VFN Praha 2 Ústav hematologie a krevní transfuze, U Nemocnice 1, Praha 2 Interní hematolonkologická klinika, FN Brno |
cz